Anatomopathological analysis allows for PTLD classification and detection of EBV mRNA expression by in situ hybridization (EBERs) or immunohistochemistry (EBNA or LMP-1 protein) in the tumor cells. This evidence concerns the gene PDLIM7 and post-transplant lymphoproliferative disease.